109676 ⎘
dsDNA viruses; Details; Adenoviridae; Mastadenovirus, e.g. human or simian adenoviruses Viruses as such, e.g. new isolates, mutants or their genomic sequences
ADENOVIRAL VECTOR VACCINE AGAINST RESPIRATORY SYNCYTIAL VIRUS, AND PREPARATION METHOD THEREFOR AND USE THEREOF
#2TUMOR SELECTIVE TATA-BOX AND CAAT-BOX MUTANTS
#3ADENOVIRAL HELPER VECTORS
#4TUMOR-SELECTIVE E1A AND E1B MUTANTS
#5ADENOVIRUS-BASED NUCLEIC ACIDS AND METHODS THEREOF
#6RECOMBINANT CHIMERIC ADENOVIRAL VECTOR SUBSTITUTED BY KNOB GENE OF CHIMPANZEE ADENOVIRUS SEROTYPE 6, AND APPLICATION THEREOF
#7VIRAL VECTOR AND RECOMBINANT SIMIAN ADENOVIRUS
#8Novel chimpanzee adenovirus vector, construction method therefor, and application thereof
#9ONCOLYTIC ADENOVIRUSES FOR TREATING CANCER
#10A549 host cells comprising a recombinant oncolytic adenovirus with modified E1A cancer-specific promoter
#11METHODS AND COMPOSITIONS FOR PRODUCING AN ADENOVIRUS VECTOR FOR USE WITH MULTIPLE VACCINATIONS
#12NEOANTIGEN ADJUVANT AND MAINTENANCE THERAPY
#13MODIFIED ADENOVIRUS
#14Desmoglein 2 (DSG2) Binding Proteins and Uses Therefor
#15METHODS AND COMPOSITIONS FOR PRODUCING AN ADENOVIRUS VECTOR FOR USE WITH MULTIPLE VACCINATIONS
#16Tumor-selective E1a and E1b mutants
#17GENERATION OF DIVERSE VIRAL LIBRARIES
#18ONCOLYTIC ADENOVIRUS WITH REPLICATION SELECTIVITY BASED ON STATUS OF P53 TRANSCRIPTIONAL ACTIVITY
#19VIRUS STABILIZER, GELATIN HYDROLYSATE FOR VIRUS STABILIZER, AND VIRUSCONTAINING COMPOSITION
#20ENGINEERED ONCOLYTIC ADENOVIRUS
#21VIRAL BIOSENSORS
#22Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
#23Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
#24METHOD FOR REVERSING MULTIPLE RESISTANCE IN ANIMAL CELLS
#25SINGLE PLASMID VECTOR SYSTEM FOR PACKAGING RECOMBINANT HUMAN ADENOVIRUS TYPE 4 AND APPLICATION THEREOF
#26ONCOLYTIC NON-HUMAN ADENOVIRUSES AND USES THEREOF
#27Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
#28PV-DELETED BOVINE ADENOVIRUS
#29Desmoglein 2 (DSG2) binding proteins and uses therefor
#30ONCOLYTIC ADENOVIRUS ENCODING A B7 PROTEIN
#31Oncolytic virus or antigen presenting cell mediated cancer therapy using type I interferon and CD40-ligand
#32Potent and balanced bidirectional promoter
#33Tumor-selective E1A and E1B mutants
#34Non human great apes adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof
#35NOVEL ADENOVIRUS
#36ONCOLYTIC ADENOVIRUS COMPOSITIONS WITH ENHANCED REPLICATION PROPERTIES
#37MODIFIED ONCOLYTIC ADENOVIRUSES
#38TROPISM MODIFIED CANCER TERMINATOR VIRUS (AD.5/3 CTV;AD.5/3-CTV-M7)
#39Combination therapy for treatment of brain cancers
#40Adenovirus and uses thereof
#41Desmoglein 2 (DSG2) binding proteins and uses therefor
#42Simian adenoviruses SAdV-43, -45, -46, -47, -48, -49, and -50, and uses thereof
#43Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
#44Life-cycle-defective adenovirus helper viruses, their production and use for producing rAAV
#45Adenovirus comprising an albumin-binding moiety
#46Adenovirus polynucleotides and polypeptides
#47Recombinant simian adenoviral vectors encoding a heterologous fiber protein and uses thereof
#48Method for producing recombinant oncolytic adenovirus with modified E1a cancer-specific promoter
#49TUMOR SELECTIVE TATA-BOX AND CAAT-BOX MUTANTS
#50MULTIPLE TRANSGENE RECOMBINANT ADENOVIRUS
#51Oncolytic adenoviruses for treating cancer
#52PV-DELETED BOVINE ADENOVIRUS
#53Tropism modified cancer terminator virus (Ad.5/3 CTV;Ad.5/3-CTV-M7)
#54Potent and balanced bidirectional promoter
#55ONCOLYTIC ADENOVIRUSES FOR CANCER TREATMENT
#56Methods and compositions for performing continuous directed evolution
#57Recombinant adenoviruses and use thereof
#58Tumor-selective E1a and E1b mutants
#59Desmoglein 2 (DSG2) binding proteins and uses therefor
#60Oncolytic adenovirus encoding a B7 protein or active fragment
#61Oncolytic adenoviruses with increased proportion of the 156R splicing isoform of the E1B protein
#62Methods for inducing an immune response
#63Subgroup B recombinant human adenovirus vector, and methods for constructing and for using the same
#64Adenovirus polynucleotides and polypeptides
#65Oncolytic adenovirus encoding a B7 protein
#66Chimpanzee clade E adenovirus nucleic acid-and amino acid-sequences, vectors containing same, and uses thereof
#67Oncolytic adenovirus encoding a B7 protein
#68Simian adenoviruses SAdV-43, -45, -46, -47, -48, -49, and -50, and uses thereof
#69Multitargeting onocolytic adenovirus, methods of use, and methods of making
#70Sequence arrangements and sequences for neoepitope presentation
#71Anti-cancer compositions containing Wnt decoy receptor
#72Oncolytic adenovirus encoding a therapeutic protein or active fragment
#73Methods for reversing multiple resistance in animal cells
#74Desmoglein 2 (DSG2) binding proteins and uses therefor
#75SIMIAN ADENOVIRUS NUCLEIC ACID AND AMINO ACID SEQUENCES, VECTORS CONTAINING SAME, AND METHODS OF USE
#76Targeted adenoviruses and methods of making, isolating, and using
#77HPV vaccines and methods of use thereof
#78Breast cancer vaccines and methods of use thereof
#79Oncolytic adenovirus encoding a B7 protein or active fragment
#80Hexon isolated from simian adenovirus serotype 19, hypervariable region thereof and chimeric adenovirus using the same
#81Adenovirus comprising an albumin-binding moiety
#82Group B adenovirus modified in the E4orf4 region
#83Oncolytic adenoviruses for cancer treatment
#84Method of making adenovirus and corresponding plasmids
#85Subfamily E simian adenoviruses A1321, A1325, A1295, A1309, A1316 and A1322 and uses thereof
#86Adenovirus isolated from titi monkeys
#87Desmoglein 2 (DSG2) binding proteins and uses therefor
#88Subgroup B recombinant human adenovirus vector, and methods for constructing and for using the same
#89Subfamily E simian adenoviruses A1302, A1320, A1331 and A1337 and uses thereof
#90ADENOVIRUSES AND THEIR USE
#91Tropism modified cancer terminator virus (Ad.5/3 CTV;AD.5/3-CTV-M7)
#92SIMIAN ADENOVIRUS NUCLEIC ACID AND AMINO ACID SEQUENCES, VECTORS CONTAINING SAME, AND METHODS OF USE
#93Oncolytic adenoviruses with increased proportion of the 156R splicing isoform of the E1B protein
#94Recombinant adenoviruses and use thereof
#95Viruses associated with immunodeficiency and enteropathy and methods using same
#96Simian adenoviruses SAdV-43, -45, -46, -47, -48, -49, and -50, and uses thereof
#97Simian adenovirus 41 and uses thereof
#98Chimeric adenoviruses for use in cancer treatment
#99Adenoviruses and their use
#100Anti-cancer compositions containing WNT decoy receptor
#101Infectivity-enhanced conditionally-replicative adenovirus and uses thereof
#102Simian subfamily E adenoviruses SAdV-39, -25.2, -26, -30, -37, and -38 and uses thereof
#103Subgroup B recombinant human adenovirus vector, and methods for constructing and for using the same
#104Batches of recombinant adenovirus with altered terminal ends
#105Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
#106Simian subfamily B adenoviruses SAdV-28, -27, -29, -32, -33, and -35 and uses thereof
#107Subfamily E simian adenoviruses A1302, A1320, A1331 and A1337 and uses thereof
#108Simian adenoviruses SAdV-36, -42.1, -42.2, and -44 and uses thereof
#109Chimeric adenoviruses for use in cancer treatment
#110Sequential administration of a replication defective adenovirus vector in vaccination protocols
#111Chimeric adenoviruses for use in cancer treatment
#112Chimeric adenoviruses for use in cancer treatment
#113HEXON ISOLATED FROM SIMIAN ADENOVIRUS SEROTYPE 19, HYPERVARIABLE REGION THEREOF AND CHIMERIC ADENOVIRUS USING THE SAME
#114Adenovirus isolated from Titi Monkeys
#115Adenovirus E1A fragments for use in anti-cancer therapies
#116Subfamily E simian adenoviruses A1321, A1325, A1295, A1309, A1316 and A1322 and uses thereof
#117Chimpanzee adenovirus vaccine carriers
#118Chimeric adenoviruses for use in cancer treatment
#119INFECTIVITY-ENHANCED CONDITIONALLY-REPLICATIVE ADENOVIRUS AND USES THEREOF
#120Simian adenovirus 41 and uses thereof
#121Oncolytic adenoviruses for treating cancer
#122Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
#123Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof
#124Tumor selective E1a and E1b mutants
#125METHODS FOR REVERSING MULTIPLE RESISTANCE IN ANIMAL CELLS
#126Simian adenoviruses SAdV-43, -45, -46, -47, -48, -49, and -50 and uses thereof
#127Generation of replication competent viruses for therapeutic use
#128Chimpanzee adenovirus vaccine carriers
#129Production of rAAV in Vero Cells Using Particular Adenovirus Helpers
#130Infectivity-enhanced conditionally-replicative adenovirus and uses thereof
#131Methods and compositions for treating cancer
#132Simian adenoviruses SAdV-36, -42.1, -42.2, and -44 and uses thereof
#133Methods for Reversing Multiple Resistance in Animal Cells
#134Simian subfamily C adenoviruses SAdV-40, -31, and -34 and uses thereof
#135Simian subfamily B adenoviruses SAdV-28, -27, -29, -32, -33, and -35 and uses thereof
#136Simian E adenoviruses SAdV-39, -25.2, -26, -30, -37, and -38
#137Sequential administration of a replication defective adenovirus vector in vaccination protocols
#138Adenovirus with mutations in the endoplasmic reticulum retention domain of the E3-19K protein and their use in cancer treatment
#139Oncolytic Adenoviruses and Uses Thereof
#140Serotype of adenovirus and uses thereof
#141Oncolytic Adenoviruses for Cancer Treatment
#142Production of rAAV in vero cells using particular adenovirus helpers
#143Chimeric adenoviruses for use in cancer treatment
#144Generation of Replication Competent Viruses for Therapeutic Use
#145Pan cancer oncolytic vectors and methods of use thereof
#146Therapy for primary and metastatic cancers
#147Stocks of replication-deficient adenovirus
#148ADENOVIRUS VECTOR AND METHOD TO MANIPULATE THE ADENOVIRUS GENOME
#149Adenovirus Serotype 26 Vectors, Nucleic Acid and Viruses Produced Thereby
#150Serotype of adenovirus and uses thereof
#151Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
#152Methods of producing erythropoietin isoforms comprising Lewis-X structures and high sialic acid content and compositions of the same
#153RECOMBINANT ADENOVIRAL VECTORS AND METHODS OF USE
#154Preservative-containing virus formulations
#155Adenoviral vectors having a protein IX deletion
#156Serotype of adenovirus and uses thereof
#157Recombinant adenoviral vector and method of use
#158Adenoviral vectors having a protein IX deletion
#159Human prolyl isomerase 1 (PIN 1) promoter and uses thereof
#160Formulations for therapeutic viruses having enhanced storage stability
#161Use of flexible bag containers for viral production
#162Recombinant adenoviral vectors and methods of use
#163Generation of replication competent viruses for therapeutic use
#164Adenoviral vectors having a protein IX deletion
#165Adenoviral vectors having a protein IX deletion
#166Vectors and methods for gene transfer
#167Chimeric adenoviruses for use in cancer treatment
#168Serotype of adenovirus and uses thereof
#169Means and methods for nucleic acid delivery vehicle design and nucleic acid transfer
#170Pan cancer oncolytic vectors and methods of use thereof
#171Compositions of erythropoietin isoforms comprising Lewis-X structures and high sialic acid content
#172Modified adenovirus containing a fiber replacement protein
#173Serotype of adenovirus and uses thereof
#174Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
#175Device for cultivating cells and propagating viruses